New emerging roles of microRNAs in breast cancer

被引:50
作者
Ayerim Mandujano-Tinoco, Edna [1 ,3 ]
Garcia-Venzor, Alfredo [1 ]
Melendez-Zajgla, Jorge [2 ]
Maldonado, Vilma [1 ]
机构
[1] Inst Nacl Med Genom, Epigenet Lab, Periferico Sur 4809, Mexico City 14610, DF, Mexico
[2] Inst Nacl Med Genom, Funct Genom Lab, Periferico Sur 4809, Mexico City 14610, DF, Mexico
[3] Inst Nacl Rehabil Luis Guillermo Ibarra Ibarra, Lab Connect Tissue, Mexico Xochimilco 289, Mexico City 14389, DF, Mexico
关键词
Cancer; Breast cancer; miRNA; Stem cells; TO-MESENCHYMAL TRANSITION; GENOMIC INSTABILITY; UP-REGULATION; TUMOR-GROWTH; NEOADJUVANT CHEMOTHERAPY; MIR-221/222; PROMOTES; CELL-PROLIFERATION; GLUCOSE-METABOLISM; SIGNALING PATHWAY; DICER EXPRESSION;
D O I
10.1007/s10549-018-4850-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background MicroRNAs constitute a large family of non-coding RNAs, which actively participate in tumorigenesis by regulating a set of mRNAs of distinct signaling pathways. An altered expression of these molecules has been found in different tumorigenic processes of breast cancer, the most common type of cancer in the female population worldwide. Purpose The objective of this review is to discuss how miRNAs become master regulators in breast tumorigenesis. Methods An integrative review of miRNAs and breast cancer literature from the last 5 years was done on PubMed. We summarize recent works showing that the defects on the biogenesis of miRNAs are associated with different breast cancer characteristics. Then, we show several examples that demonstrate the link between cellular processes regulated by miRNAs and the hallmarks of breast cancer. Finally, we examine the complexity in the regulation of these molecules as they are modulated by other non-coding RNAs and the clinical applications of miRNAs as they could serve as good diagnostic and classification tools. Conclusion The information presented in this review is important to encourage new directed studies that consider microRNAs as a good tool to improve the diagnostic and treatment alternatives in breast cancer.
引用
收藏
页码:247 / 259
页数:13
相关论文
共 116 条
[71]  
Oliveto Stefania, 2017, World J Biol Chem, V8, P45, DOI 10.4331/wjbc.v8.i1.45
[72]  
Pan Y, 2016, SCI REP-UK, V6, DOI [10.1038/srep25798, 10.1038/srep28632]
[73]   Tumour angiogenesis regulation by the miR-200 family [J].
Pecot, Chad V. ;
Rupaimoole, Rajesha ;
Yang, Da ;
Akbani, Rehan ;
Ivan, Cristina ;
Lu, Chunhua ;
Wu, Sherry ;
Han, Hee-Dong ;
Shah, Maitri Y. ;
Rodriguez-Aguayo, Cristian ;
Bottsford-Miller, Justin ;
Liu, Yuexin ;
Kim, Sang Bae ;
Unruh, Anna ;
Gonzalez-Villasana, Vianey ;
Huang, Li ;
Zand, Behrouz ;
Moreno-Smith, Myrthala ;
Mangala, Lingegowda S. ;
Taylor, Morgan ;
Dalton, Heather J. ;
Sehgal, Vasudha ;
Wen, Yunfei ;
Kang, Yu ;
Baggerly, Keith A. ;
Lee, Ju-Seog ;
Ram, Prahlad T. ;
Ravoori, Murali K. ;
Kundra, Vikas ;
Zhang, Xinna ;
Ali-Fehmi, Rouba ;
Gonzalez-Angulo, Ana-Maria ;
Massion, Pierre P. ;
Calin, George A. ;
Lopez-Berestein, Gabriel ;
Zhang, Wei ;
Sood, Anil K. .
NATURE COMMUNICATIONS, 2013, 4
[74]  
Poursadegh Zonouzi Ali Akbar, 2017, Breast Dis, V37, P55, DOI 10.3233/BD-170274
[75]   Differential response of normal and transformed mammary epithelial cells to combined treatment of anti-miR-21 and radiation [J].
Radulovic, Vanja ;
Heider, Theresa ;
Richter, Sabine ;
Moertl, Simone ;
Atkinson, Michael J. ;
Anastasov, Natasa .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2017, 93 (04) :361-372
[76]   miRNA-Mediated RNA Activation in Mammalian Cells [J].
Ramchandran, Ramani ;
Chaluvally-Raghavan, Pradeep .
RNA ACTIVATION, 2017, 983 :81-89
[77]   MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer [J].
Raychaudhuri, Mithu ;
Bronger, Holger ;
Buchner, Theresa ;
Kiechle, Marion ;
Weichert, Wilko ;
Avril, Stefanie .
BREAST CANCER RESEARCH AND TREATMENT, 2017, 162 (03) :511-521
[78]   Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer [J].
Rhodes, Lyndsay V. ;
Martin, Elizabeth C. ;
Segar, H. Chris ;
Miller, David F. B. ;
Buechlein, Aaron ;
Rusch, Douglas B. ;
Nephew, Kenneth P. ;
Burow, Matthew E. ;
Collins-Burow, Bridgette M. .
ONCOTARGET, 2015, 6 (18) :16638-16652
[79]   microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer [J].
Rostas, Jack W., III ;
Pruitt, Hawley C. ;
Metge, Brandon J. ;
Mitra, Aparna ;
Bailey, Sarah K. ;
Bae, Sejong ;
Singh, Karan P. ;
Devine, Daniel J. ;
Dyess, Donna L. ;
Richards, William O. ;
Tucker, J. Allan ;
Shevde, Lalita A. ;
Samant, Rajeev S. .
MOLECULAR CANCER, 2014, 13
[80]   MicroRNA therapeutics: towards a new era for the management of cancer and other diseases [J].
Rupaimoole, Rajesha ;
Slack, Frank J. .
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (03) :203-221